Prospective Validation of a New Priority Allocation Model for Liver Transplant Candidates: An Interim Analysis

Transplantation Proceedings

Volumn 41, Issue 4, 2009, Pages 1092-1095

  Vitale, A ^a,b   Saracino, E ^c   D'Amico, F E ^a   Grigoletto, F ^c   Burra, P ^c   Angeli, P ^c   Boccagni, P ^a   Brolese, A ^a   Zanus, G ^a   Neri, D ^a   Gringeri, E ^a   D'Amico, F ^a   Valmasoni, M ^a   Carraro, A ^a   Gambato, M ^c   Feltracco, P ^c   Romano, A ^d   Buggio, M ^a   D'Amico, D F ^a   Cillo, U ^a  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONTROL GROUP; CONTROLLED STUDY; DATA ANALYSIS; DISEASE MODEL; FEMALE; GRAFT FAILURE; GRAFT SURVIVAL; HEALTH CARE PLANNING; HOSPITAL ADMISSION; HUMAN; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER GRAFT; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; PREVALENCE; PRIORITY JOURNAL; RECIPIENT; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; TREATMENT WITHDRAWAL; VALIDATION STUDY; CARCINOMA, HEPATOCELLULAR; DONOR; END STAGE LIVER DISEASE; LIVER NEOPLASMS; MIDDLE AGED; MORTALITY; PROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; TRANSPLANTATION; YOUNG ADULT;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; END STAGE LIVER DISEASE; FEMALE; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS; WAITING LISTS; YOUNG ADULT;

EID: 65549105407     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.03.053     Document Type: Article

References (9)

1. Harper A.M., Edwards E.B., and Eleison M.D. The OPTN waiting list, 1988-2000. Clin Transplant 73 (2001)
2. Freeman Jr. R.B. The Model for End-stage Liver Disease comes of age. Clin Liver Dis 11 (2007) 249
3. Freeman R.B., Edwards E.B., and Harper A.M. Waiting list removal rates among patients with chronic and malignant liver disease. Am J Transpl 6 (2006) 1416
4. Merion R.M., Schaubel D.E., Dykstra D.M., et al. The survival benefit of liver transplantation. Am J Transplant 5 (2005) 307
5. Ioannou G.N., Perkins J.D., and Carithers R.L. Liver transplantation for hepatocellular carcinoma: impact of the MELD allocation system and predictors of survival. Gastroenterology 134 (2008) 1342
6. Segev D.L., Maley W.R., Simpkins C.E., et al. Minimizing risk associated with elderly liver donors by matching to preferred recipients. Hepatology 46 (2007) 1907
7. Vitale A., D'Amico F., Brolese A., et al. Prognostic impact of model for end-stage liver disease score in patients undergoing liver transplantation with suboptimal livers. Transplant Proc 39 (2007) 1907
8. D'Amico F., Vitale A., Gringeri E., et al. Liver transplantation using suboptimal grafts: impact of donor harvesting technique. Liver Transpl 13 (2007) 1444
9. Cillo U., Vitale A., Grigoletto F., et al. Intention-to-treat analysis of liver transplantation in selected, aggressively treated HCC patients exceeding the Milan criteria. Am J Transplant 7 (2007) 972